Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

The eye provides a unique, open, and accessible window for directly imaging small vessels in the retina with non-invasive techniques, such as fundoscopy. In this context, accurate registration of ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

A common phrase that macular degeneration patients hear is "There's nothing more we can do". But it couldn't be furth ...

The main outcomes were change in mean VA from baseline, number of injections and clinic visits and characteristics affecting VA change and DR grade. Results Data from 12 989 clinic visits was collated ...

Dr Agarwals Eye Hospital ... management of inherited retinal dystrophies, and the exciting future of AI in disease management. Our hands-on Wet Lab courses, focusing on techniques like Glued IOL, SFT, ...

All of the four patients with the palpebral form of essential blepharospasm preferred the Riolan's injections. They, previously, had hardly been able to open their eyes. Twenty- six of the ...